18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.

Ryan Avery; Phillip H. Kuo

doi:10.1097/rlu.0b013e3182996138

18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.

Ryan Avery^*, Phillip H. Kuo

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Intense FDG uptake by bone marrow following recent chemotherapy limits evaluation for osseous metastases. The impact of marrow rebound on accuracy of (18)F-fluoride PET/CT is unclear. A 73-year-old woman with breast cancer presented for restaging FDG PET/CT, which showed intense activity throughout almost the entire axial skeleton and no osseous metastases. An (18)F-fluoride PET/CT performed 7 days later identified multiple osseous metastases in the spine, ribs, and pelvis. This case demonstrates that (18)F-fluoride PET/CT should be considered for the evaluation of osseous metastases in patients with rebound marrow uptake on FDG PET/CT.

Original language	English (US)
Pages (from-to)	746-748
Number of pages	3
Journal	Clinical nuclear medicine
Volume	38
Issue number	9
DOIs	https://doi.org/10.1097/rlu.0b013e3182996138
State	Published - Sep 2013

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/rlu.0b013e3182996138

Cite this

@article{0379c992785a4229aa70199478989aed,

title = "18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.",

abstract = "Intense FDG uptake by bone marrow following recent chemotherapy limits evaluation for osseous metastases. The impact of marrow rebound on accuracy of (18)F-fluoride PET/CT is unclear. A 73-year-old woman with breast cancer presented for restaging FDG PET/CT, which showed intense activity throughout almost the entire axial skeleton and no osseous metastases. An (18)F-fluoride PET/CT performed 7 days later identified multiple osseous metastases in the spine, ribs, and pelvis. This case demonstrates that (18)F-fluoride PET/CT should be considered for the evaluation of osseous metastases in patients with rebound marrow uptake on FDG PET/CT.",

author = "Ryan Avery and Kuo, {Phillip H.}",

year = "2013",

month = sep,

doi = "10.1097/rlu.0b013e3182996138",

language = "English (US)",

volume = "38",

pages = "746--748",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.

AU - Avery, Ryan

AU - Kuo, Phillip H.

PY - 2013/9

Y1 - 2013/9

N2 - Intense FDG uptake by bone marrow following recent chemotherapy limits evaluation for osseous metastases. The impact of marrow rebound on accuracy of (18)F-fluoride PET/CT is unclear. A 73-year-old woman with breast cancer presented for restaging FDG PET/CT, which showed intense activity throughout almost the entire axial skeleton and no osseous metastases. An (18)F-fluoride PET/CT performed 7 days later identified multiple osseous metastases in the spine, ribs, and pelvis. This case demonstrates that (18)F-fluoride PET/CT should be considered for the evaluation of osseous metastases in patients with rebound marrow uptake on FDG PET/CT.

AB - Intense FDG uptake by bone marrow following recent chemotherapy limits evaluation for osseous metastases. The impact of marrow rebound on accuracy of (18)F-fluoride PET/CT is unclear. A 73-year-old woman with breast cancer presented for restaging FDG PET/CT, which showed intense activity throughout almost the entire axial skeleton and no osseous metastases. An (18)F-fluoride PET/CT performed 7 days later identified multiple osseous metastases in the spine, ribs, and pelvis. This case demonstrates that (18)F-fluoride PET/CT should be considered for the evaluation of osseous metastases in patients with rebound marrow uptake on FDG PET/CT.

UR - http://www.scopus.com/inward/record.url?scp=84894553409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894553409&partnerID=8YFLogxK

U2 - 10.1097/rlu.0b013e3182996138

DO - 10.1097/rlu.0b013e3182996138

M3 - Article

C2 - 23797230

AN - SCOPUS:84894553409

SN - 0363-9762

VL - 38

SP - 746

EP - 748

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 9

ER -

18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this